Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2014; 6(02): 096-101
DOI: 10.4103/0974-2727.141506
Original Article

The Epidemiological Profile of Candidemia at an Indian Trauma Care Center

Vibhor Tak
Department of Laboratory Medicine, JPNA Trauma Center, New Delhi, India
,
Purva Mathur
Department of Laboratory Medicine, JPNA Trauma Center, New Delhi, India
,
Prince Varghese
Department of Microbiology, AIIMS, New Delhi, India
,
Jacinta Gunjiyal
Department of Microbiology, AIIMS, New Delhi, India
,
Immaculata Xess
Department of Hospital Infection Control, JPNA Trauma Center, New Delhi, India
,
Mahesh C Misra
Department of Surgery, JPNA Trauma Center, New Delhi, India
› Author Affiliations Source of Support: Nil
› Further Information
  PDF Download Permissions and Reprints

ABSTRACT

Purpose: Candida spp. is a common cause of bloodstream infections. Candidemia is a potentially fatal infection that needs urgent intervention to salvage the patients. Trauma patients are relatively young individuals with very few comorbidities, and the epidemiology of candidemia is relatively unknown in this vulnerable and growing population. In this study, we report the epidemiology of candidemia in a tertiary care Trauma Center of India.

Materials and Methods: The study was conducted from January 2009 to July 2012. All patients from whose blood samples a Candida spp. was recovered were included in this study. A detailed history and follow up of the patients was done. The isolates of Candida were identified to the species level. The speciation was done by conventional methods, including morphology on Corn Meal Agar, color development on Triphenyl Tetrazolium Chloride Agar and CHROMagar, and germ tube tests. The VITEK 2 YST ID colorometric card, a fully automated identification system was also used. Antifungal susceptibility was performed using the VITEK 2 system.

Results: A total of 212 isolates of the Candida species were recovered from blood samples of 157 patients over the study period. Candida tropicalis, 82 (39%), was the most common, followed by C. parapsilosis, 43 (20%), C. albicans, 29 (14%), C. glabrata, 24 (11%), C. rugosa, 20 (9%), C. hemulonii,; 6 (3%), C. guilliermondii, 4 (2%), C. famata, 3 (1.5%), and C. lusitaniae 1 (0.5%). Out of all the candidemia patients, 68 (43%) had a fatal outcome. Fluconazole and Amphotericin B resistance was seen in seven (3.3%) and seven (3.3%) of the isolates, respectively.

Conclusion: Candidemia is a significant cause of mortality in trauma patients in our center, with C. tropicalis and C. parapsilosis being the predominant pathogens. Resistance to antifungal drugs is a matter of concern. Better hospital infection control practices and good antibiotic stewardship policies could possibly help in reducing the morbidity and mortality associated with candidemia.

Keywords

Antifungal resistance - blood stream infections - candidemia - trauma


Publication History

Article published online:
19 April 2020

© 2014.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
  • 2 Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends 1991-2000. Clin Infect Dis 2004;38:311-20.
  • 3 Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 2005;41:1232-9.
  • 4 Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: Data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009;48:1695-703.
  • 5 Gudlaugsson O, Gillespie S, Lee K, Vande BJ, Hu J, Messer S, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003;37:1172-7.
  • 6 Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998;27:781-8.
  • 7 Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5.
  • 8 Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21.
  • 9 Nguyen MH, Peacock JE, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995;155:2429-35.
  • 10 Nucci M, Colombo AL, Silveira F, Richtmann R, Salomao R, Branchini ML, et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998;19:846-50.
  • 11 Mean M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008;12:204-12.
  • 12 Bouza E, Munoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008;32 Suppl 2:S87-91.
  • 13 Pfaller MA, Diekema DJ. Epidemiology of Invasive Candidiasis: A Persistent Public Health Problem. Clin Microbiol Rev 2007;20:133-63.
  • 14 Sobel JD. The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. Curr Infect Dis Rep 2006;8:427-33.
  • 15 Washington WC, Koneman EW, Stephen DA, Gary WP, Paul SC, William JM, et al. Koneman′s Colour Atlas and Textbook of Diagnostic Microbiology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006.
  • 16 Taylor G, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Long term trends in the occurrence of nosocomial blood stream infection. Can J Infect Dis 2000;11:29-33.
  • 17 Ellis M, Hedstrom U, Jumaa P, Bener A. Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001. Med Mycol 2003;41:521-8.
  • 18 Narang A, Agarwal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis at a tertiary care neonatal unit. J Trop Pediatr 1998;44:104-8.
  • 19 Chakrabarti A, Chatterjee SS, Shivaprakash MR. Overview of opportunistic fungal infections in India. Jpn J Med Mycol 2008;49:165-72.
  • 20 Rennert G, Rennert HS, Pitlik S, Finkelstein R, Kitzes-Cohen R. Epidemiology of candidemia-A nationwide survey in Israel. Infection 2000;28:26-9.
  • 21 Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, Cuna T, et al. Epidemiology of invasive fungal infections in the intensive care unit: Results of a multicenter Italian survey (AURORA Project). Infection 2013;41:645-53.
  • 22 Gonzalez de Molina FJ, Leon C, Ruiz-Santana S, Saavedra P. CAVA I Study Group. Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care 2012;16:R105.
  • 23 Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Michael Rinaldi, et al. National Epidemiology of Mycoses Survey (NEMIS): Variations in Rates of Bloodstream Infections Due to Candida Species in Seven Surgical Intensive Care Units and Six Neonatal Intensive Care Units. Clin Infect Dis 1999;29:253-8.
  • 24 Chakrabarti A, Mohan B, Shrivastava SK, Marak RS, Ghosh A, Ray P. Change in distribution and antifungal susceptibility of Candida species isolated from Candidaemia cases in a tertiary care center during 1996-2000. Indian J Med Res 2002;116:5-12.
  • 25 Chakrabarti A, Chatterjee SS, Rao KL, Zameer MM, Shivaprakash MR, Singhi S, et al. Recent experience with fungaemia: Change in species distribution and azole resistance. Scand J Infect Dis 2009;41:275-84.
  • 26 Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care center of North India: 5 year study. Infection 2007;35:256-9.
  • 27 Singh RI, Xess I, Mathur P, Behera B, Gupta B, Misra MC. Epidemiology of candidemia in critically ill trauma patients: Experiences of a level I trauma center in North India. J Med Microbiol 2011;60:342-8.
  • 28 Ajenjo HM, Aquevedo SA, Guzmán DA, Poggi MH, Calvo AM, Castillo VC, et al. Epidemiological profile of invasive candidiasis in critically ill patients units at a University Hospital. Rev Child Infect 2011;28:118-22.
  • 29 Wolf DG, Polacheck I, Block C, Sprung CL, Muggia-Sullam M, Wolf YG, et al. High rate of Candidemia in patients sustaining injuries in a bomb blast at a marketplace: A possible environmental source. Clin Infect Dis 2000;31:712-6.
  • 30 Bougnoux ME, Kac G, Aegerter P, d′Enfert C, Fagon JY; CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: Incidence, molecular diversity, management and outcome. Intensive Care Med 2008;34:292-9.
  • 31 Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011;6:e24198.